You will be redirected to https://www.worldscientific.com/apbn to view or purchase the issue PDF.
EDITORIAL
BioBoard
Australia • Well-known antibiotic amoxycillin found to be ineffective cough treatment • Bring the noise: has technology made us scared of silence?
India • Biocon receives marketing authorization for novel biologic itolizumab for psoriasis
Israel • Aspireo reports Somatoprim Phase Ib interim data
Japan • Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy for autoimmune disease • Eisai signs agreement with Epizyme and Roche Molecular Systems to develop companion diagnostic
The Philippines • Asia-Pacific Analysis: The growth of stem-cell therapy • Is the world ready for scientific diplomacy?
United Kingdom • ARIAD and the U.K. National Cancer Research Institute to collaborate on SPIRIT 3 clinical study • Vision research collaboration on novel treatment for wet age-related macular degeneration
United States • Reducing medical mistakes: Two recently published studies support the use of DNA testing on biopsy samples to prevent misdiagnoses • CoDa Therapeutics reports positive results from Phase IIb Study of NEXAGON® in chronic venous leg ulcers • Inovio Pharmaceuticals to initiate clinical trial for its hepatitis C therapeutic vaccine later this year • Jolt to brain eases pain without drugs • Can a new vaccine prevent colon cancer? • Immunovaccine’s DPX-Survivac produces sustained, dose related immune responses in Phase I ovarian cancer study
Eye on China • NCKU researcher develops new use of reservoir sediment • WILEX Inc. and GeneDiagnostics Inc. enter into partnership for the IVD approval and distribution of the serum HER-2/neu test • Celsion Corporation and Zhejiang Hisun Pharmaceutical Company enter into technology development agreement for ThermoDox® for the Greater China Territory • SFDA grants approval for clinical studies to benapenem • UroFlex now CE-marked; Chinese SFDA approval for Cellvizio • China National Genebank and Smithsonian’s National Museum of Natural History collaborate on biobanking to advance biodiversity research • New analytical method for uleine alkaloids having anticancer activity • Zhifei Biological’s vaccine approved for clinical test • EntreMed files new drug clinical trial application for ENMD-2076 with China SFDA to advance global development strategy
Features • The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan • Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan • Recombinant Lipoproteins for the Development of Novel Subunit Vaccines • Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology
People Watch • The Crystal Ball on Biosimilars with Dr. Anthony Rebuck
Inside Industry • Cognoptix licenses AD detection technology • 3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement • Medicago is awarded contract from the U.S. Department of Defence for potential future production • Clinical Network Services (CNS) acquires New Zealand partner BELTAS’ business assets • VABIOTECH licenses cell-based Japanese encephalitis technology from Inviragen • University of Illinois licenses novel anti-cancer therapies to StemPar Sciences • Adimab announces new discovery collaboration with Kyowa Hakko Kirin • Priaxon enters collaboration with GSK on protein-protein-interactions • Lantheus Medical Imaging and FUJIFILM RI Pharma renew long-term license and distribution agreement for Cardiolite and Neurolite in Japan
• Conference Calendar